Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study

Background: The population with myocardial infarction (MI) undergoing primary percutaneous coronary intervention (PPCI) is growing, but validated models to guide their clinical management are lacking. This study aimed to develop and validate prognostic models to predict major adverse cardiovascular...

Full description

Bibliographic Details
Main Authors: Xiaoxiao Zhao, Chen Liu, Peng Zhou, Zhaoxue Sheng, Jiannan Li, Jinying Zhou, Runzhen Chen, Ying Wang, Yi Chen, Li Song, Hanjun Zhao, Hongbing Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.603621/full
_version_ 1818383874126774272
author Xiaoxiao Zhao
Chen Liu
Peng Zhou
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Runzhen Chen
Ying Wang
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
Hongbing Yan
author_facet Xiaoxiao Zhao
Chen Liu
Peng Zhou
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Runzhen Chen
Ying Wang
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
Hongbing Yan
author_sort Xiaoxiao Zhao
collection DOAJ
description Background: The population with myocardial infarction (MI) undergoing primary percutaneous coronary intervention (PPCI) is growing, but validated models to guide their clinical management are lacking. This study aimed to develop and validate prognostic models to predict major adverse cardiovascular events (MACEs) in patients with MI undergoing PPCI.Methods and Results: Models were developed in 4,151 patients with MI who underwent PPCI in Fuwai Hospital between January 2010 and June 2017, with a median follow-up of 698 days during which 544 MACEs occurred. The predictors included in the models were age, a history of diabetes mellitus, atrial fibrillation, chronic kidney disease, coronary artery bypass grafting, the Killip classification, ejection fraction at admission, the high-sensitivity C-reactive protein (hs-CRP) level, the estimated glomerular filtration rate, the d-dimer level, multivessel lesions, and the culprit vessel. The models had good calibration and discrimination in the derivation and internal validation with C-indexes of 0.74 and 0.60, respectively, for predicting MACEs. The new prediction model and Thrombolysis in Myocardial Infarction (TIMI) risk score model were compared using the receiver operating characteristic curve. The areas under the curve of the new prediction model and TIMI risk score model were 0.806 and 0.782, respectively (difference between areas = 0.024 < 0.05; z statistic, 1.718).Conclusion: The new prediction model could be used in clinical practice to support risk stratification as recommended in clinical guidelines.
first_indexed 2024-12-14T03:13:18Z
format Article
id doaj.art-c8c5c34f0e314677982e68568622d8ca
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-14T03:13:18Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-c8c5c34f0e314677982e68568622d8ca2022-12-21T23:19:12ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-11-01710.3389/fcvm.2020.603621603621Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation StudyXiaoxiao Zhao0Chen Liu1Peng Zhou2Zhaoxue Sheng3Jiannan Li4Jinying Zhou5Runzhen Chen6Ying Wang7Yi Chen8Li Song9Hanjun Zhao10Hongbing Yan11Hongbing Yan12Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, ChinaBackground: The population with myocardial infarction (MI) undergoing primary percutaneous coronary intervention (PPCI) is growing, but validated models to guide their clinical management are lacking. This study aimed to develop and validate prognostic models to predict major adverse cardiovascular events (MACEs) in patients with MI undergoing PPCI.Methods and Results: Models were developed in 4,151 patients with MI who underwent PPCI in Fuwai Hospital between January 2010 and June 2017, with a median follow-up of 698 days during which 544 MACEs occurred. The predictors included in the models were age, a history of diabetes mellitus, atrial fibrillation, chronic kidney disease, coronary artery bypass grafting, the Killip classification, ejection fraction at admission, the high-sensitivity C-reactive protein (hs-CRP) level, the estimated glomerular filtration rate, the d-dimer level, multivessel lesions, and the culprit vessel. The models had good calibration and discrimination in the derivation and internal validation with C-indexes of 0.74 and 0.60, respectively, for predicting MACEs. The new prediction model and Thrombolysis in Myocardial Infarction (TIMI) risk score model were compared using the receiver operating characteristic curve. The areas under the curve of the new prediction model and TIMI risk score model were 0.806 and 0.782, respectively (difference between areas = 0.024 < 0.05; z statistic, 1.718).Conclusion: The new prediction model could be used in clinical practice to support risk stratification as recommended in clinical guidelines.https://www.frontiersin.org/articles/10.3389/fcvm.2020.603621/fullmyocardial infarctionprimary percutaneous coronary interventionMACEderivationvalidation
spellingShingle Xiaoxiao Zhao
Chen Liu
Peng Zhou
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Runzhen Chen
Ying Wang
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
Hongbing Yan
Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
Frontiers in Cardiovascular Medicine
myocardial infarction
primary percutaneous coronary intervention
MACE
derivation
validation
title Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
title_full Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
title_fullStr Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
title_full_unstemmed Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
title_short Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
title_sort estimation of major adverse cardiovascular events in patients with myocardial infarction undergoing primary percutaneous coronary intervention a risk prediction score model from a derivation and validation study
topic myocardial infarction
primary percutaneous coronary intervention
MACE
derivation
validation
url https://www.frontiersin.org/articles/10.3389/fcvm.2020.603621/full
work_keys_str_mv AT xiaoxiaozhao estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT chenliu estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT pengzhou estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT zhaoxuesheng estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT jiannanli estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT jinyingzhou estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT runzhenchen estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT yingwang estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT yichen estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT lisong estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT hanjunzhao estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT hongbingyan estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy
AT hongbingyan estimationofmajoradversecardiovasculareventsinpatientswithmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionariskpredictionscoremodelfromaderivationandvalidationstudy